SREBF1 and steatosis: The impaired regulation of key pathways, such as reduced SREBF1-driven lipogenesis and altered cholesterol/bile acid homeostasis, could promote hepatocellular injury and fibrogenesis, increasing the risk of progression from simple steatosis to steatohepatitis and advanced liver disease.